Advanced Precision Therapies For Cancer
A Better Approach to Cancer Immunotherapy
Black Canyon Bio is developing novel products for treating cancer using our proprietary Specific Neo-Antigen Peptides (SNAP) Technology platform.
SNAP has product development applications across many cancers and other diseases.
SNAP uniquely enables cancer treatments to target individualized markers on a patient’s tumor called neoantigens. Our proprietary approach enables the credentialing of these neoantigens to facilitate enhanced clinical efficacy. SNAP extends promising new therapeutic approaches while overcoming key challenges, especially for treating solid tumors.
Best-in-Class Therapeutic Cancer Vaccines
Lead Program:
SNAPduo 101 peptide cancer vaccine for virus-associated cancers will begin clinical testing in 2026.
Meet the Team
-
Kenneth Carter, PhD
EXECUTIVE CHAIRMAN
-
Sunil Sharma, MD, FACP, MBA
CHIEF MEDICAL OFFICER
-
Juan Montesinos, MD, MS
CHIEF OPERATING OFFICER
-
Michael King, MBA
CHIEF FINANCIAL OFFICER
-
Daniel-Paul Bednarík, PhD
CHIEF TECHNOLOGY OFFICER
-
Raffaela Soldi, PhD
VP OF RESEARCH
-
Alexis Weston
HEAD OF STRATEGY
Contact Us
Interested in working together?
Fill out some info, and we will be in touch shortly. We can’t wait to hear from you!